XNAS 05 May, 2026 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Matthew K. Szot | Director | Sale of securities on an exchange or to another person at price $ 1.50 per share. | 03 Dec 2025 | 4 | 3 | - | 1.5 | 6 | Common stock |
| Matthew K. Szot | Director | Other type of transaction at price $ 0.00 per share. | 03 Dec 2025 | 3 | 0 | - | 0 | Common stock | |
| Steven M. Shum | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2025 | 42,000 | 42,451 | - | - | Stock Option (right to buy) | |
| Barbara Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2025 | 45,000 | 45,157 | - | - | Stock Option (right to buy) | |
| Rebecca Messina | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2025 | 45,000 | 45,143 | - | - | Stock Option (right to buy) | |
| Trent D. Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2025 | 45,000 | 45,159 | - | - | Stock Option (right to buy) | |
| Andrea Goren | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2025 | 50,000 | 50,409 | - | - | Stock Option (right to buy) | |
| Matthew K. Szot | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2025 | 45,000 | 45,164 | - | - | Stock Option (right to buy) | |
| Rebecca Messina | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 85,000 | 85,000 | - | - | Stock Option (right to buy) | |
| Matthew K. Szot | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 85,000 | 85,000 | - | - | Stock Option (right to buy) | |
| Andrea Goren | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 81,000 | 81,000 | - | - | Stock option (right to buy) | |
| Trent D. Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 85,000 | 85,000 | - | - | Stock Option (right to buy) | |
| Steven M. Shum | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Michael J. Campbell | Director, Chief Operating Officer | 18 May 2023 | 83,000 | 83,000 | - | - | Stock Option (right to buy) | ||
| Barbara Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 85,000 | 85,000 | - | - | Stock Option (right to buy) | |
| Kevin Doody | Director, Medical Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2022 | 9,088 | 9,088 | - | - | Stock Option | |
| Barbara Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2022 | 10,435 | 10,435 | - | - | Stock Option | |
| Barbara Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2022 | 8,588 | 21,053 | - | 0 | Common Stock | |
| Jeffrey Segal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2022 | 9,762 | 9,762 | - | - | Stock Option | |
| Jeffrey Segal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2022 | 8,034 | 18,009 | - | 0 | Common Stock | |
| Michael J. Campbell | Director, Chief Operating Officer | 15 Jan 2022 | 18,513 | 18,513 | - | - | Stock Option | ||
| Michael J. Campbell | Director, Chief Operating Officer | 15 Jan 2022 | 15,236 | 65,236 | - | 0 | Common Stock | ||
| Kevin Doody | Director, Medical Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2022 | 7,480 | 177,306 | - | 0 | Common Stock | |
| Matthew K. Szot | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2022 | 10,250 | 24,701 | - | 0 | Common Stock | |
| Matthew K. Szot | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2022 | 12,454 | 12,454 | - | - | Stock Option | |
| Andrea Goren | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2022 | 15,197 | 15,197 | - | - | Stock Option | |
| Andrea Goren | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2022 | 5,361 | 17,861 | - | 0 | Common Stock | |
| Trent D. Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2022 | 10,771 | 10,771 | - | - | Stock Option | |
| Trent D. Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2022 | 8,865 | 22,438 | - | 0 | Common Stock | |
| Steven M. Shum | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2022 | 20,111 | 82,035 | - | 0 | Common Stock | |
| Steven M. Shum | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2022 | 57,018 | 57,018 | - | - | Stock Option | |
| Rebecca Messina | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2022 | 8,311 | 13,177 | - | 0 | Common Stock | |
| Rebecca Messina | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2022 | 10,098 | 10,098 | - | - | Stock Option | |
| Steven M. Shum | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.26 per share. | 05 Oct 2021 | 30,674 | 61,924 | - | 3.3 | 99,997 | Common Stock |
| Andrea Goren | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 3.26 per share. | 05 Oct 2021 | 30,674 | 76,383 | - | 3.3 | 99,997 | Common Stock |
| Rebecca Messina | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2021 | 6,239 | 6,239 | - | - | Stock Option | |
| Rebecca Messina | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2021 | 4,806 | 4,806 | - | 0 | Common Stock | |
| Matthew K. Szot | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Nov 2020 | 2,339 | 2,339 | - | 0 | Common Stock | |
| Barbara Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Nov 2020 | 2,317 | 2,317 | - | - | Stock Option | |
| Barbara Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Nov 2020 | 2,317 | 2,317 | - | 0 | Common Stock | |
| Jeffrey Segal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Nov 2020 | 1,137 | 1,137 | - | - | Stock Option | |
| Jeffrey Segal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Nov 2020 | 1,137 | 1,137 | - | 0 | Common Stock | |
| Matthew K. Szot | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Nov 2020 | 2,339 | 2,339 | - | - | Stock Option |